1
|
Nasser BA, Mesned AR, Tageldein M, Kabbani MS, Sayed NS. Can acute-phase response biomarkers differentiate infection from inflammation postpediatric cardiac surgery? Avicenna J Med 2021; 7:182-188. [PMID: 29119086 PMCID: PMC5655650 DOI: 10.4103/ajm.ajm_51_17] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
Background: Infection is a common serious complication postpediatric cardiac surgery. Diagnosis of infection after cardiopulmonary bypass (CPB) is difficult in the presence of surgical stress, hemodynamic instability, and inflammatory reaction. Aim: The purpose of this study is to investigate the value of available inflammatory biomarkers and its validity to differentiate infection from inflammation postpediatric cardiac surgery and to find the trend and the change in the level of these biomarkers shortly after cardiac surgery. Methods: We conducted a prospective study that included all children who underwent cardiac surgery in Prince Sultan Cardiac Centre-Qassim from November 2013 to October 2015. C-reactive protein, erythrocyte sedimentation rate, white blood cell count, and neutrophil count were measured for all patients presurgery, 4 consecutive days postsurgery, and predischarge. Patients were divided into two groups (the infected and the noninfected group). We compared the level of biomarkers between both groups. Then, we further analyzed the effects of CPB and preoperative steroid on postoperative inflammatory biomarker levels. Collected data were then reviewed and analyzed. Results: There were 134 pediatric cardiac patients included during the study period. Group 1 (bacterial negative culture group) had 125 cases and Group 2 (bacterial positive culture group) had nine cases. We found no statistically significant difference in inflammatory biomarker elevation between both groups. Only Group 2 had higher (RACHS) Risk adjustment for congenital heart surgery score, more ventilator days, and more drop in platelet count on the 2nd and 3rd postoperative days in comparison with the noninfected group 1. Both groups of patients who were in on and off CPB had the same level of inflammatory biomarkers with no significant differences. Giving corticosteroid preoperatively did not affect the trend of biomarker elevation and made no difference when it was compared to the group of patients who did not receive corticosteroid before surgery. Conclusion: Common inflammatory biomarkers cannot differentiate between infection and inflammation within the first 5 days postpediatric cardiac surgery as these reflect the inflammatory process rather than infection. Trend is more important than single reading.
Collapse
Affiliation(s)
- Bana Agha Nasser
- Prince Sultan Cardiac Center, Pediatric Cardiac Intensive Care, Qassim, Kingdom of Saudi Arabia
| | - Abdu Rahman Mesned
- Prince Sultan Cardiac Center, Pediatric Cardiac Intensive Care, Qassim, Kingdom of Saudi Arabia
| | - Mohamad Tageldein
- Prince Sultan Cardiac Center, Pediatric Cardiac Surgery, Qassim, Kingdom of Saudi Arabia
| | - Mohamed S Kabbani
- Department of Cardiac Sciences, Pediatric Cardiac Intensive Care, King Abdulaziz Medical City, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia
| | - Nada Siddig Sayed
- Prince Sultan Cardiac Center, Pediatric Cardiac Surgery, Qassim, Kingdom of Saudi Arabia
| |
Collapse
|
2
|
Juliana J, Sembiring YE, Rahman MA, Soebroto H. Mortality Risk Factors in Tetralogy of Fallot Patients Undergoing Total Correction. FOLIA MEDICA INDONESIANA 2021. [DOI: 10.20473/fmi.v57i2.22107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
A total correction is a preferred treatment for Tetralogy of Fallot patients in every part of the world. However, the mortality in developing countries was as high as 6.9% to 15.3%. This was a retrospective analytic study that analyzed pre and post-operative risk factors that affected mortality on TOF patients that were performed total correction in Indonesia. A total of 47 TOF patients that were performed total correction from January 2016 to September 2019 were enrolled in this study based on the inclusion criteria. Preoperative and post-operative data were obtained from medical records. In this research, the majority of mortality was found in male patients (39.3%), while the female’s rate was lower (36.8%). Overall mortality was 38.3% and one operative death was found. The average age of patients was 84.12 months (12-210 months), whereas the average height (85.56 ± 36.17cm vs. 112.93 ± 21.73) and weight (17.22kg vs. 28.21kg) were lower for mortality patients. Some significant preoperative variables were identified as mortality risk factors such as: age below 60 months (p=0.047), smaller weight and height (p=0.008; p=0.002), abnormal hematocrit (p=0.002), and oxygen saturation below 75% (p=0.018). Significant post-operative risk factors included: temperature above 38.5⁰C (p=0.000), and ventilator time of more than 48 hours (p=0.033). In conclusion, the mortality of TOF patients undergoing a total correction in developing countries was quite high. It was associated with some risk factors, such as younger age, lower weight and height, low oxygen saturation, post-operative fever, and prolonged ventilator time.
Collapse
|
3
|
Shaker R, Arabi M, Khafaja S, Fayad D, Casals AA, Lteif M, Shamseddine S, Taqa MA, Charafeddine F, Rassi IE, Al-Halees Z, Bitar F, Hanna-Wakim R, Dbaibo G. Placement of Labcor Pulmonary Conduit Results in a High Incidence of Postoperative Fever. World J Pediatr Congenit Heart Surg 2021; 12:55-60. [PMID: 33407033 DOI: 10.1177/2150135120956995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND Fever in the postoperative period in cardiac patients is common. The purpose of this study is to recognize the risk factors for prolonged postoperative fever in cardiac patients with pulmonary conduit insertion. METHODS Patients were identified retrospectively by looking at the International Classification of Diseases, Ninth Revision, Clinical Modification procedure code for pulmonary conduit insertion between June 2009 and December 2015 at the American University of Beirut Medical Center. Data about preoperative, perioperative, and postoperative variables were collected. Data entry and analysis were performed using SPSS version 22. RESULTS The study identified 59 patients. The most common type of pulmonary conduit used was the Contegra type (57.6%) (n = 34), followed by the Labcor type (20.3%; n = 12). Postoperative fever occurred in 61% of patients (n = 36). Fourteen patients (38.8%) had a prolonged fever that lasted for more than seven days. Prolonged postoperative fever was significantly associated with the Labcor pulmonary conduit (P value < .001) and a longer duration of pacing wires (P value: .039). Significantly prolonged fever that lasted for more than 21 days occurred in five patients who all had inserted the Labcor pulmonary conduit. CONCLUSIONS The Labcor pulmonary conduit type is a risk factor for prolonged postoperative fever. The protracted use of pacing wires could be a consequence of the prolonged fever rather than a cause. In the absence of a demonstrable infectious etiology for prolonged postoperative fever in cardiac patients with pulmonary conduit insertion, the Labcor pulmonary conduit could be the underlying cause. Alternative management of such cases may lead to decreased antibiotic use and morbidity.
Collapse
Affiliation(s)
- Rouba Shaker
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Division of Pediatric Infectious Diseases, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Center for Infectious Diseases Research, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Mariam Arabi
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Division of Pediatric Cardiology, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Children's Heart Center, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Sarah Khafaja
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Center for Infectious Diseases Research, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Danielle Fayad
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Center for Infectious Diseases Research, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Aia Assaf Casals
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Division of Pediatric Infectious Diseases, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Center for Infectious Diseases Research, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Mireille Lteif
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Center for Infectious Diseases Research, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Sarah Shamseddine
- Center for Infectious Diseases Research, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Mohammad Abu Taqa
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Division of Pediatric Cardiology, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Children's Heart Center, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Fatmeh Charafeddine
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Division of Pediatric Cardiology, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Children's Heart Center, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Issam El Rassi
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Division of Pediatric Cardiology, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Children's Heart Center, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Department of Surgery, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Zoheir Al-Halees
- Division of Pediatric Cardiology, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Children's Heart Center, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Department of Surgery, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Heart Center, 37852King Faisal Specialist Hospital and Research center, Riyadh, Saudi Arabia
| | - Fadi Bitar
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Division of Pediatric Cardiology, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Children's Heart Center, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Department of Biochemistry and Molecular Genetics, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Rima Hanna-Wakim
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Division of Pediatric Infectious Diseases, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Center for Infectious Diseases Research, 66984American University of Beirut Medical Center, Beirut, Lebanon
| | - Ghassan Dbaibo
- Department of Pediatrics and Adolescent Medicine, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Division of Pediatric Infectious Diseases, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Center for Infectious Diseases Research, 66984American University of Beirut Medical Center, Beirut, Lebanon.,Department of Biochemistry and Molecular Genetics, 66984American University of Beirut Medical Center, Beirut, Lebanon
| |
Collapse
|
4
|
Post-operative fever (POF) after cardiac surgery in a low- and middle-income-country: 7-year institutional experience. Cardiol Young 2021; 31:352-357. [PMID: 33558001 DOI: 10.1017/s1047951121000214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND Post-operative fever (POF) after cardiac surgery in a developing country is of great concern because of the associated morbidity and mortality. In our country, we experience this complication more because of a high rate of malaria infestations, gastroenteritis, and malnutrition. We also experience a low yield of positive diagnostic tests when POF develops; this is partly due to expense and the prioritisation of other essential items in our poorly equipped cardiac ICU. AIMS/OBJECTIVE To assess the causes of POF after cardiac surgery and determine its impact on the outcome on patients. MATERIALS AND METHODS International Cardiac Surgery Mission teams visited our centre for 7 years (2013-2019). During this period, a significant number of cardiac surgeries were performed. A retrospective study of patients with POF was performed with data from our hospital's database, and included standard demographics; types of surgery performed, and management protocols being used in the peri-operative care. RESULTS A total of 242 patients were treated during the study period and underwent 266 surgeries. Of these, 151 (56.8%) and 115 (43.2%) were adult and paediatric cases respectively. Ages ranged between 0 and 90 years; 34 (14.1%) had POF. When we evaluated the clinical and associated laboratory findings, pyrexia (temp >38.0 °C) and elevated white blood cell count with differential neutrophilia were present in 10 patients (29.4%). The time of onset and duration of POF were between <24 and >144 hours. In the invasive procedure related to POF, sternotomy infections were present in seven patients (18.4%). Malaria infestations and breach in sterility protocol were predominant. CONCLUSION The management of POF in the cardiac ICU was complicated by the requirement of co-operation from a larger number of specialties than is usually required in advanced centres with special expertise in malaria confirmation. We, therefore, introduced structured clinical, laboratory, and appropriate interventions to treat POF more aggressively. We found that more careful attention to peri-operative details to ensure strict observation of sterility protocol with anti-malaria prophylaxis led to improvements in our centre's outcomes.
Collapse
|
6
|
Abdollahi MH, Foruzan-Nia K, Behjati M, Bagheri B, Khanbabayi-Gol M, Dareshiri S, Pishgahi A, Zarezadeh R, Lotfi-Naghsh N, Lotfi-Naghsh A, Naghavi-Behzad M. The effect of preoperative intravenous paracetamol administration on postoperative fever in pediatrics cardiac surgery. Niger Med J 2014; 55:379-83. [PMID: 25298601 PMCID: PMC4178333 DOI: 10.4103/0300-1652.140376] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/17/2023] Open
Abstract
Background: Post-operative fever is a common complication of cardiac operations, which is known to be correlated with a greater degree of cognitive dysfunction 6 weeks after cardiac surgery. The aim of the present study was to examine efficacy and safety of single dose intravenous Paracetamol in treatment of post-operative fever in children undergoing cardiac surgery. Materials and Methods: In this randomised, double-blind, placebo-controlled clinical trial, 80 children, aged 1-12 years, presenting for open heart surgery were entered in the trial and randomly allocated into two groups: Placebo and Paracetamol. After induction of anaesthesia, 15 mg/kg intravenous Paracetamol solution was infused during 1 h in the Paracetamol group. Patients in placebo group received 15 mg/kg normal saline infusion during the same time. Since the end of operation until next 24 h in intensive care unit, axillary temperature of the two group patients was recorded in 4-h intervals. Any fever that occurred during this period had been treated with Paracetamol suppository (125 mg) and the amount of antipyretic drug consumption for each patient had been recorded. In order to examine the safety of Paracetamol, patients were evaluated for drug complication at the same time. Results: Mean axillary temperature during first 24 h after operation was significantly lower in Paracetamol group compared with placebo group (P = 0.001). Overall fever incidence during 24 h after operation was higher in placebo group compared with Paracetamol group (P = 0.012). Of Paracetamol group patients, 42.5% compared with 15% of placebo group participants had no consumption of antipyretic agent (Paracetamol suppository) during 24 h after operation (P = 0.001). Conclusion: This study suggests that single dose administration of intravenous Paracetamol before paediatric cardiac surgeries using cardiopulmonary bypass; reduce mean body temperature in the first 24 h after operation.
Collapse
Affiliation(s)
| | - Khalil Foruzan-Nia
- Department of Cardiac Surgery, Shahid Sadoghi University of Medical Science, Yazd, Iran
| | - Mostafa Behjati
- Department of Pediatrics, Shahid Sadoghi University of Medical Science, Yazd, Iran
| | - Babak Bagheri
- Department of Cardiology, Mazandaran University of Medical Science, Mazandaran, Iran
| | - Mehdi Khanbabayi-Gol
- Department of Internal-Surgical, Tabriz University of Medical Science, Tabriz, Iran
| | - Shahla Dareshiri
- Department of Psychiatry, Tabriz University of Medical Science, Tabriz, Iran
| | - Alireza Pishgahi
- Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Science, Tabriz, Iran
| | - Rafie Zarezadeh
- Department of Anesthesia, Shahid Sadoghi University of Medical Science, Yazd, Iran
| | - Nazgol Lotfi-Naghsh
- Department of Anesthesiology and Reanimatology, Medical Faculty, Hacettepe University, Ankara, Turkey
| | - Ainaz Lotfi-Naghsh
- Students' Research Committee, Tabriz University of Medical Science, Tabriz, Iran
| | - Mohammad Naghavi-Behzad
- Students' Research Committee, Tabriz University of Medical Science, Tabriz, Iran ; Medical Philosophy and History Research Center, Tabriz University of Medical Science, Tabriz, Iran
| |
Collapse
|